# Genetic Determinants of Response to Neoadjuvant Cisplatin-based Chemotherapy in Urothelial Cancer

> **NCT01206426** · — · COMPLETED · sponsor: **University of Chicago** · enrollment: 79 (actual)

## Conditions studied

- Urothelial Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01206426
- **Lead sponsor:** University of Chicago
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2016-07
- **Final completion:** 2017-10-16
- **Target enrollment:** 79 (ACTUAL)
- **Last updated:** 2018-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01206426

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01206426, "Genetic Determinants of Response to Neoadjuvant Cisplatin-based Chemotherapy in Urothelial Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01206426. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*